Metastat Insights
Back to Medical Devices

Infusion Pump Software Market

Infusion Pump Software Market By Application (General Infusion, Pain, Anesthesia Management, Insulin Infusion, Enteral Infusion, Chemotherapy, Pediatrics, Neonatology, Hematology, Gastroenterology, and Others), By Infusion Method (Intravenous, Arterial, Subcutaneous, and Epidural), By End User (Hospitals, Clinics, Home Healthcare, Ambulatory, Surgical Centers, and Others), Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

Report ID

MSI-2820

Published

March 4, 2026

Pages

253 Pages

Format
Market Size 2026
Leadership Strategies
Key Trends
Market Size 2033

Report Details

Comprehensive Market Analysis And Insights

End of Report Overview

Frequently Asked Questions

Find answers to common questions about this report

Global Infusion Pump Software market is valued at $426.6 million in 2024.

Global Infusion Pump Software market is estimated to grow with a CAGR of 7.6% from 2024 to 2031.

Global Infusion Pump Software market is estimated to reach $728.9 million by 2031.

Top players operating in the Infusion Pump Software industry includes BD, ICU Medical, B. Braun, Moog, Baxter, Medtronic, Fresenius Kabi, Terumo Medical, and Others.

Medical Devices Research Team

The analysts below cover Medical Devices research at Metastat Insights.

UTKARSH KHIRODKAR

LEAD ANALYST

Utkarsh Khirodkar is a Lead Market Research Analyst at MetaStat Insight, specializing in market intelligence, technology sector assessments, and competitive strategy.

AJAY DEVGIRE

LEAD PRINCIPAL ANALYST, PHARMA AND HEALTHCARE

Food and Beverages Β· Healthcare Β· Healthcare IT Β· Medical Devices

Ajay Devgire is the Lead Healthcare Analyst at MetaStat Insight, leading strategic research and market intelligence initiatives across the global healthcare domain.

SNEHAL PASALKAR

SENIOR RESEARCH ANALYST

Biotechnology Β· Food and Beverages Β· Medical Devices Β· Packaging

Snehal Pasalkar is a Research Analyst at MetaStat Insight, operating at the intersection of life sciences research, competitive strategy, and market intelligence.

What our clients say

Evaluating secondary resin quality across post-consumer packaging streams requires reliable technical segmentation. MetaStat Insight delivered an objective assessment that distinguished between extrusion-grade flake pricing and optical sorting throughput limitations across Western Europe. The competitive positioning breakdown for licensed depolymerization technology providers answered several questions during our feedstock feasibility audit. Their team clarified regional trade restrictions on mixed plastic scrap quickly when our team submitted follow-up requests.
D

Dow Inc.

Senior Director of Circular Economy Strategy

Evaluating sovereign cloud deployments for core banking platforms demands a clear view of data residency regulations and migration exit strategies. MetaStat Insight delivered an exhaustive review of regional latency tolerances, mainframe decommission milestones, and third-party vendor concentration risk. The regulatory compliance mapping across European and Asian financial jurisdictions gave our team a dependable baseline for multi-cloud infrastructure discussions.
J

JPMorgan Chase

Director, FinTech Strategy

Replacing petrochemical surfactants with bio-based alternatives requires realistic timelines on industrial precision fermentation scaling. The market research broke down commercialization timelines, feedstock sugar price sensitivities, and regional cosmetic ingredient regulatory approvals in Europe and East Asia. That supplier readiness mapping gave our formulations team reliable context when comparing renewable chemical sourcing roadmaps.
L

L'OrΓ©al

Sourcing Director, Raw Materials and Formulations

Related Reports

Explore related market intelligence reports worth reading alongside this one.